Clinical trial
Allogeneic Bone Marrow Transplantation With Matched Unrelated Donors for…
NCT00208923 · Emory University, Other · Completed
Key facts
| NCT number | NCT00208923 |
|---|---|
| Title | Allogeneic Bone Marrow Transplantation With Matched Unrelated Donors for Patients With Hematologic Malignancies |
| Official title | Allogeneic Bone Marrow Transplantation With Matched Unrelated Donors for Patients With Hematologic Malignancies Using a Preparative Regimen of Busulfan, Cyclophosphamide, and Fludarabine |
| Lead sponsor | Emory University, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hematologic Malignancies |
| Intervention type | Drug |
| Interventions | Busulfan, Cyclophosphamide and Fludarabine |
| Enrollment | 55 |
| Start date | Jul 1, 1998 |
| Primary completion | Oct 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Sep 21, 2005 |
| Last update posted | Apr 6, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: